Efficiency and Safety of Autologous Stem Cell Transplantation for Primary Systemic Amyloidosis

HUANG Xiang-hua,WANG Qing-wen,SHI Ming-jun,CHEN Wen-cui,JIANG Song,GONG De-hua,ZENG Cai-hong,ZILAO Min,MU Zhi-hong

DOI: https://doi.org/10.3969/j.issn.1006-298x.2011.04.003

2011-01-01

Abstract:Objective:To evaluate the short time efficiency and safety of autologous hematopoietic stem cell transplantation(AHSCT) in primary systemic amyloidosis(AL).Methodology:A total of thirteen patients with biopsy-proven amyloidosis shown to be immunoglobulin light-chain type were enrolled on this study.The method of mobilization was granulocyte-colony-stimulating factor(G-CSF) alone.The patients received AHSCT in 2～6 weeks after collection.The condition regimen was high dose melphalan,the dose adjusted to 100 mg/m2,140 mg/m2 and 200 mg/m2 according to patient stratification.The assessment of organ involvement and treatment response was according to the consensus opinion from the 10th international symposium on amyloid and amyloidosis.Results:The primary clinical symptoms of these patients was nephritic syndrome.The clonal light chain subtype,classified by immunohistochemical staining,was κ in 2 patients and λ in 11 patients.The involved organ number was 1～3,which in the kidneys(100%),heart(76.9%),liver(15.4%),and peripheral nerves(7.7%).Four patients were untreated before AHSCT,while others were received induction therapy.All patients were collected enough stem cells.The main complications of collections were hypocalcemia,hypopotassaemia and thrombocytopenia.The number of CD34+ cells was 2.0～8.36 106/kg [(4.02±2.01)×106/kg].All patients had successful engraftment,and achieved a granulocyte count of 500/L between day 9 and day 13(median 9d),and an untransfused platelet count of 20 000/L from day 10 to day 21(median 13d).The major complications of peri-transplantation period were nausea/vomiting(84.6%),mucositis(76.9%),fever(53.8%),arrhythmia(53.8%),acute renal injury(46.2%) and diarrhea(30.8%).The uncommon complications were acute liver injury,hepatic rupture,pleural effusion,sepsis and so on.One patient died of transplant-related hepatic rupture at the day 21.The treatment related mortality was 7.7% in day 100.After follow up for 4～10 months,8 patients achieved hematologic response,5 had complete response and 3 had partial response.Seven patients achieved organ response,3 cases had renal and heart response,and 4 had renal response only.Conclusion:The AHSCT was an efficient and safe treatment for AL in selected patients,the hematologic and organ response rate was high.Though the complications of peri-transplantation were common,the fatal complication was rare.The long-term outcomes need future observation.